Use of the National Cancer Institute Community Cancer Centers Program Screening and Accrual Log to Address Cancer Clinical Trial Accrual. JOP 10 , e73-e80 (2014). DOI: 10.1200/JOP.2013.001194 ...

At the end of the trial, there were 35 and 19 enrollments (1.6% and 0.9%, respectively) using the AI-assisted screening and manual screening methods (subdistribution HR, 1.79).

The parties announced a collaboration in November 2023 under which Quest will have exclusive rights to provide clinical laboratory services in the U.S. assuming FDA approval for the test.

Châtillon, France, September 23, 2024. In Q3 2024, DBV exceeded its recruitment goal and successfully closed the screening process for the VITESSE Phase 3 study evaluating the Viaskin ® Peanut ...

References: Unlu O, Varugheese M, Shin J, et al. Manual vs AI-Assisted Prescreening for Trial Eligibility Using Large Language Models-A Randomized Clinical Trial. JAMA. 2025 Feb 17:e2428047. doi ...